Dr. Tom Coburn: Legislation reworks how FDA would approves drugs

Dr. Tom Coburn, senior fellow, Manhattan Institute

The 21st Century Cures Act is now wrapping up in Congress and headed to the President's desk. It would profoundly change how the Food and Drug Administration goes about its principal work of approving drugs and medical devices. Dr. Tom Coburn, former Oklahoma senator and now a senior fellow at the Manhattan Institute, joins Federal Drive with Tom Temin on the bill and its goals.


Sign up for breaking news alerts